bibliographicCitation |
Cheetham S, Tang MJ, Mesak F, Kennecke H, Owen D, Tai IT. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response. British Journal of Cancer. 2008 May 06;98(11):1810–9. doi: 10.1038/sj.bjc.6604377. |